4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-22-000002
Chairman, CEO & President sold 22,674 shares at an average $435.56 ($9,875,800)
- Chairman, CEO & President acquired 38,586 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SAYER KEVIN R Chairman, CEO & President | 2022-01-18 | Sale | −3,000 | $438.81 | $1,316,430 | 78,705 | D |
| SAYER KEVIN R Chairman, CEO & President | 2022-01-18 | Grant or award | +38,586 | 117,291 | D | ||
| SAYER KEVIN R Chairman, CEO & President | 2022-01-18 | Sale | −19,674 | $435.06 | $8,559,370 | 97,617 | D |
| Open-market sales · 22,674 sh · avg $435.56 · $9,875,800 | |||||||
Loading xslF345X03/edgardoc.xml…